Morning Briefing
Summaries of health policy coverage from major news organizations
ARV Given To HIV-Positive Children Boosts Preventive Power Of Key Malaria Drug, Study Shows
An antiretroviral (ARV) drug given to HIV-positive children "can boost the preventive power of a key malaria drug," according to a study conducted in Uganda and presented last week at the 19th Conference on Retroviruses and Opportunistic Infections, ScienceNow reports. The researchers, led by clinicians Diane Havlir of the University of California, San Francisco (UCSF), and Moses Kamya of Makerere University College of Health Sciences, "compare[d] two different cocktails of anti-HIV drugs, only one of which contained protease inhibitors, in HIV-infected children who live in a malarial area of [Uganda]" and found "that one protease inhibitor indeed helped stave off malaria."
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
